Eos Posts -849.1% Net Margin Despite 631.8% Revenue Jump — Buy or Flee?

From a capital allocation standpoint, Eos Energy Enterprises looks like a high-risk scaling story: revenue grew 631.8% to $114.2 million in FY2025, but the company still lost $969.6 million before tax and burned roughly $265 million in free cash flow. NANO Nuclear presents the opposite profile — no revenue, no commercialization, and full dependence on regulatory milestones — making this less a growth comparison than a debate over where speculative capital belongs in a clean power portfolio.

The Motley Fool's September 20, 2026 comparison of Eos Energy Enterprises (NASDAQ:EOSE) and NANO Nuclear Energy (NASDAQ:NNE) frames a central question for clean power investors in 2026: whether to pay for rapid commercial scaling today or buy a speculative claim on decentralized nuclear generation tomorrow. Eos ended fiscal 2025 with roughly $114.2 million in revenue, a 631.8% jump from the prior year, as utilities and developers began adopting its aqueous zinc batteries for long-duration storage. That top-line trajectory is counterbalanced by a pre-tax net loss of approximately $969.6 million, a net margin of negative 849.1%, and negative free cash flow near $265.0 million. NANO Nuclear, by contrast, is pre-revenue and developing compact microreactors whose path to market runs through complex licensing and safety reviews. A companion Motley Fool comparison with GE Vernova (NYSE:GEV) adds a third lens: an incumbent whose installed base helps generate about 25% of the world's electricity.

“

That top-line trajectory is counterbalanced by a pre-tax net loss of approximately $969.6 million, a net margin of negative 849.1%, and negative free cash flow near $265.0 million.

Eos's zinc technology is credible in the energy transition because it avoids lithium-ion supply chain concentration and provides longer-duration storage, but its financials reveal the brutal cost of scaling hardware. The December 2025 balance sheet shows a current ratio of about 4.9x, suggesting ample short-term liquidity, yet the debt-to-equity ratio of roughly -1.0x indicates total liabilities exceed shareholder equity, a negative-equity condition that raises solvency questions. Customer concentration is another risk: two customers accounted for roughly 70.3% of 2025 revenue, meaning the loss of one large buyer could erase a significant chunk of sales. For climate-focused investors, that is the trade-off: a commercially available non-lithium storage option with severe margin and concentration issues.

NANO Nuclear's microreactor pitch is inherently longer-dated. The company's compact reactor design targets decentralized power for remote sites, industrial users, and communities, but because it has not yet commercialized or generated revenue, its valuation rests on milestones such as regulatory approval, demonstration projects, and eventual orders. The comparison in the source treats this as a 'risk and reward' balance, but the risk profiles are not equivalent: Eos has demonstrated market demand but negative profitability, while NANO has not yet demonstrated commercial demand at all. In that sense, the better 2026 buy hinges on an investor's time horizon and tolerance for binary regulatory outcomes.